ABOUT THIS EPISODE
Behavioral inertia has become a buzzword in marketing, often associated with the stubborn action (or inaction) of a target audience. As anthropologists, Sonika and Gabe are often approached with the challenge of designing interventions that break inertia; however, there's more to inertia than simply recognizing it and knowing how to overcome it. In this episode, they break down the emotional motivators of inertia, the possibility of leveraging and rewarding inert behaviors, and why it's paramount to focus first on what a target audience is doing as opposed to what they aren't.
English
United States
TRANSCRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
SEARCH PAST EPISODES
Search past episodes of Breaking the Code .
OTHER EPISODES IN THIS PODCAST
In this episode, we are joined by Eirásmin Lokpez-Cobo, EVP of Brand Strategy at República Havas Health, to dive into the insights from her team's recently published white paper, Equity in Action: Mapping the Multicultural Patient Journey for Inclusive Strategies (link below). This insightful …
Thinking holistically is easy to say, but hard to do, especially when designing strategies to change behavior within a specific role like patient, HCP, or caregiver. In this episode, Sonika and Gabe unpack how they disrupt their own thinking to uncover culturally resonant insights and drive more im…
The biggest health story of the year has been how GLP-1s like Ozempic are reshaping everyday life. As the holidays approach, we take a closer look at an unexpected cultural shift—the shape of Santa Claus. For nearly a century, Santa has been celebrated as a holly jolly figure with a long white bear…
Women's professional sports are "having a moment", but this did not happen in a vacuum nor did it happen overnight. In a highly anticipated episode (for us), we finally got a chance to sit down with Claire Knapp (CEO of Havas Lynx) and Denise Melone (Managing Director of Havas Life S…
With the advent of GLP-1 drugs, it was only a matter of time before Brad and Gabriel dove into a discussion about this controversial drug class and the equally contentious disease, obesity. In this episode, they explore a range of topics—from the history of obesity and its recognition as a disease …
Disclaimer: The podcast and artwork embedded on this page are from Havas Medical Anthropology, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.
